June 22, 2022--Researched by Industrial Info Resources (Sugar Land, Texas)--The World Trade Organization's (WTO) action last week to ease intellectual property protection for COVID-19 vaccines and therapeutics has caused an uproar across the globe. Such a move has been in discussion for a couple of years, but until now, nothing was official. The stated point of the move was to ensure global availability of the drugs, including lower-income countries, by bypassing a company's patents on vaccines and other products. Essentially, this will allow manufacturers in developing countries to override patents on the vaccines and export them for sale in other lower-income countries. While some of the countries that would expect to benefit from this are indeed supportive of the plan, the drug industry and trade associations are not.
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×Contact Us
For More Info!